To access this element change to forms mode OFF
Grant Award View - GA207567
Exploiting a novel cell surface biomarker to defeat multiple myeloma
GA ID:
GA207567
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
4-Jan-2022
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2025
Value (AUD):
$908,658.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Exploiting a novel cell surface biomarker to defeat multiple myeloma
Purpose:
Multiple myeloma is an incurable aggressive cancer of the bone marrow. In Australia, ~2,500 new cases are diagnosed every year with a 5 year survival rate of ~50% and treatment costs exceeding $700,000 per patient. We have identified a single cell surface protein to be upregulated by ~20% of myeloma patients who are then 3 times more likely to die within 6 years of diagnosis. This study examines a new prognostic tool to rapidly identify poor prognosis patients and new a target to treat them.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2013460
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of South Australia
Recipient ABN:
37 191 313 308
Grant Recipient Location
Suburb:
Mawson Lake
Town/City:
Mawson Lake
Postcode:
5095
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, SA, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED STATES